A study on cancer screening in HIV-infected hemophiliacs

A study on cancer screening in HIV-infected hemophiliacs - Hemophilia cancer study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038231

Enrollment

Registered

2019-10-10

Start date

2019-11-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

Chest and abdominal CT scan including thyroid and prostate, gastric endoscopy, stool occult blood, and tumor markers of AFP, CEA, and PSA are performed twice with over one-year interval for the NADM s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)HIV-infected hemophiliacs who are attending an out-patient clinic of ACC (2)A written informed consent was obtained.

Exclusion criteria

Exclusion criteria: (1)Severe underlying and/or active AIDS diseases that need to be treated. (2)Patients who have difficulty to participate in this study due to psychological diseases. (3)Patients who are judged to be inappropriate in participation by the attending doctor.

Design outcomes

Primary

Measure	Time frame
To demonstrate incidence of NADM in HIV-infected hemophiliacs	—

Secondary

Measure	Time frame
To demonstrate background data of the patients and kinds of cancers diagnosed	—

Countries

Japan

Contacts

Public ContactShinichi Oka

National Center for Global Health and Medicine AIDS Clinical Center

oka@acc.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026